| Literature DB >> 33415989 |
Jurica Novak1, Hrvoje Rimac1,2, Shivananda Kandagalla1, Maria A Grishina1, Vladimir A Potemkin1.
Abstract
Background: The SARS-CoV-2 3CLpro is one of the primary targets for designing new and repurposing known drugs. Methodology: A virtual screening of molecules from the Natural Product Atlas was performed, followed by molecular dynamics simulations of the most potent inhibitor bound to two conformations of the protease and into two binding sites.Entities:
Keywords: 3CLpro; COVID-19; SARS-CoV-2; futalosine; molecular dynamics; natural product atlas
Year: 2021 PMID: 33415989 PMCID: PMC7798421 DOI: 10.4155/fmc-2020-0248
Source DB: PubMed Journal: Future Med Chem ISSN: 1756-8919 Impact factor: 3.808